Concepedia

Shoron Mowla

SM

Statistics

Publications

7

Citations

387

H-Index

7

Active since

2021

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Boston Children's Hospital

Icahn School of Medicine at Mount Sinai

Institute of Hematology & Blood Diseases Hospital

Harvard University

Shoron Mowla is an author at Memorial Sloan Kettering Cancer Center specializing in life sciences, oncology, and molecular oncology.

ORCID

Publications per year

2021–2024

7

Publications

7

MEN1 mutations mediate clinical resistance to menin inhibition

Florian Perner, Eytan M. Stein, Daniela V. Wenge et al. · Nature · 2023 · 243 citations · Full text

, , +9

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

Andrew Dunbar, Dongjoo Kim, Min Lü et al. · Blood · 2023 · 37 citations · Full text

, , +12

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Bing Li, Wenbin An, Hua Wang et al. · Blood · 2022 · 35 citations · Full text

, , +15

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Andrew Dunbar, Robert L. Bowman, Young C. Park et al. · Cancer Discovery · 2024 · 30 citations · Full text

, , +16

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Raajit K. Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara et al. · Clinical Cancer Research · 2021 · 22 citations · Full text

, , +17

1–5 of 7